on Wednesday announced that this Friday the immunization against coronavirus of adults aged above 80, who reside in Lima and Callao, will kick off.
In this sense, the Head of State pointed out that the goal is to vaccinate 718,000 elders over 80 years old, followed by citizens aged 70-79 and 60-69.
The statesman explained that the new plan has a territorial approach, prioritizing the areas at highest risk, and will be carried out based on the pattern of the
Pongo el Hombro (I lend the shoulder) digital platform through which it will be possible to get to know where, when, and the time at which it corresponds getting vaccinated.
I lend the shoulder
The President explained that the
Pongo el Hombro (I lend the shoulder) platform will allow the elderly to be centralized in a single registry, regardless of whether they belong to the Ministry of Health, the Social Health Insurance System (EsSalud), private insurance providers, or military and police institutions, as happened during the first stage of vaccination.
Vaccines
Likewise, the top official informed that —of one million Sinopharm vaccines— 98% of the first dose and 78% of the second dose have been administered, adding that his administration expects to conclude the inoculation with these doses by the end of April.
Concerning the Pfizer doses —purchased directly from the pharmaceutical company and through the
COVAX Facility mechanism— 87.3% of the first dose and 36% of the second dose have been administered.
Moreover, the statesman indicated that 276,000
AstraZeneca vaccines will come through
COVAX this month, followed by an additional 1.09 million doses in May. "Thus, we will be able to continue vaccinating the elderly and vulnerable people quickly," he commented.
Mr. Sagasti specified that AstraZeneca doses will be distributed mostly nationwide, since the refrigeration conditions (between 2 and 8 Celsius degrees) enable the government to do so.
He also indicated that those under 60 years of age —who are vulnerable— will be incorporated into the vaccination, with the support of the Ethics Commission.
(END) FHG/VVS/MVB